Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection

Suresh M Ganesan1, Joanne M Morrisey, Hangjun Ke

  • 1Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 W. Queen Lane, Philadelphia, PA 19129, USA.

Insights

Researchers developed a new selectable marker for genetically modifying Plasmodium falciparum, enabling multiple transfections. This yeast-derived ubiquinone-independent dihydroorotate dehydrogenase (yDHODH) allows for efficient gene disruption in malaria parasites.

Area of Science:

  • Molecular Biology
  • Parasitology
  • Genetics

Background:

  • Genetic manipulation of Plasmodium falciparum is crucial for understanding its biology but is limited by available selectable markers.
  • Existing methods for transfecting malaria parasites are cumbersome and restrict the number of simultaneous genetic modifications possible.

Purpose of the Study:

  • To develop and validate a novel selectable marker for Plasmodium falciparum transfections.
  • To assess the utility of yeast-derived ubiquinone-independent dihydroorotate dehydrogenase (yDHODH) as a positive selectable marker.
  • To demonstrate its application in gene disruption strategies for Plasmodium falciparum.

Main Methods:

  • Constructed a transfection vector (pUF-1) incorporating the yDHODH gene for positive selection and a yeast cytosine deaminase-uracil phosphoribosyl transferase gene for negative selection.
  • Transfected Plasmodium falciparum strains (D10 and Dd2) and selected for transgenic parasites using various inhibitors.
  • Performed gene disruption of the PfVP2 gene via double crossover recombination.

Main Results:

  • Successfully used yDHODH as a positive selectable marker in the D10 strain with atovaquone, and in both D10 and Dd2 strains using Plasmodium DHODH-specific triazolopyrimidine-based inhibitors.
  • DHODH inhibitors proved superior, enabling selection in the Dd2 strain and reducing selection time.
  • Demonstrated proof-of-concept by successfully disrupting the PfVP2 gene, indicating it's non-essential for blood-stage survival.

Conclusions:

  • Yeast-derived ubiquinone-independent dihydroorotate dehydrogenase (yDHODH) serves as a versatile and effective positive selectable marker for Plasmodium falciparum transfections.
  • DHODH inhibitors offer a robust selection method, particularly for strains like Dd2, and expedite the process.
  • This new marker facilitates advanced genetic studies, including gene disruption, advancing our understanding of malaria parasite biology.

Related Concept Videos